Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
FOXO Technologies Inc. (FOXO)
USD0.11
+0.00 (+0.00%)
US OTC Healthcare Medical - Healthcare Information Services
Address
729 North Washington Avenue 55401
West Palm Beach, MN, US
West Palm Beach, MN, US
CEO
Seamus Lagan
Website
foxotechnologies.com
IPO
2022-09-16
CIK 1812360 ISIN US3514715032
Description
FOXO Technologies Inc. operates as a technology platform company primarily focused on translating longevity science into practical applications for the life insurance sector. The firm is actively creating products and services that integrate scientific understanding of longevity with life insurance offerings. The dual objectives of these innovations are to encourage greater consumer involvement in their health and wellness, and to streamline the often-complex insurance underwriting process for customers. Among its key offerings is FOXO Labs, a service-oriented platform that enhances the customer underwriting experience by incorporating saliva-based epigenetic biomarkers into expedited underwriting procedures. Additionally, the company provides FOXO Life, an insurance products platform. This platform offers a combination of FOXO's own unique life insurance products and policies from third-party carriers, all designed to bundle longevity science with life insurance. FOXO Technologies Inc. was established in 2019 and is headquartered in Minneapolis, Minnesota.
News Sentiment (7d)
Based on only 2 articles — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.11
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
2.2K
Beta
2.32
Float Shares
4.90M
Free Float %
16.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | -75.00% | +0.00% | -99.99% | -100.00% | -100.00% | -100.00% | -100.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.11
Quality scores
Altman Z-Score
-7.92
Distress
Piotroski F-Score
4 / 9
Average
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Healthcare Information Services: +14.2%+304.0% ★ Q1'26: +63.0% (vs Q1'25)
-
EPS growth Medical - Healthcare Information Services: +43.1%+86.0% ★ Q1'26: +98.6% (vs Q1'25)
-
FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%-29.3% Q1'26: -11.3% (vs Q1'25)
-
EBIT margin Medical - Healthcare Information Services: +8.8%-56.2% Q1'26: +0.0% (vs Q1'25)
-
ROIC Medical - Healthcare Information Services: +5.2%-42.1% Q1'26: +0.0% (vs Q1'25)
-
Share dilution Medical - Healthcare Information Services: -0.1%+1,712.1% Q1'26: +10,278.8% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×-1.28× Q1'26: -10.43× (vs Q1'25)
Valuation Multiples
From
To
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-14 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-13 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-12 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-11 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 5/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
2.28B
OE per share TTM
477.90
Owner's Yield
732,600.09%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
20,470.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
14
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Sabes | 6.03M | 18.20% | 6.03M | — | 6.03M | — | IN | or place of organization | 2022-09-26 | ↗ |
| 2 | GWG Holdings, Inc. | 4.65M | 17.10% | 4.65M | — | 4.65M | — | CO | Delaware | 2023-06-02 | ↗ |
| 3 | J. DOWLING, JR. | 2.50M | 9.18% | — | 2.50M | — | — | IN | UNITED STATES | 2023-06-22 | ↗ |
| 4 | Mark Brian White | 1.55M | 17.33% | 250.0K | 1.30M | 250.0K | — | IN | Citizenship or place of organization | 2024-02-05 | ↗ |
| 5 | Matin Christopher Ward | 1.55M | 17.33% | 250.0K | 1.30M | 250.0K | — | IN | Citizenship or place of organization | 2024-02-05 | ↗ |
| 6 | PARTNERS, LLC | 1.30M | 4.79% | — | 1.30M | — | — | OO | UNITED STATES | 2023-06-22 | ↗ |
| 7 | Spencer C Christopher | 1.30M | 14.53% | — | 1.30M | — | — | IN | Citizenship or place of organization | 2024-02-15 | ↗ |
| 8 | TAIL PARTNERS, LLC | 1.20M | 4.41% | — | 1.20M | — | — | OO | UNITED STATES | 2023-06-22 | ↗ |
| 9 | Management, LLC | 1.16M | 3.50% | — | 1.16M | — | 1.16M | OO | or place of organization | 2022-09-26 | ↗ |
| 10 | Health, Inc. | 1.02M | 7.63% | 1.02M | — | 1.02M | — | CO | — | 2024-08-05 | ↗ |
| 11 | EIN: 88-345-9534 | 600.0K | 8.20% | 600.0K | — | 6.00M | — | OO | Delaware | 2023-12-08 | ↗ |
| 12 | Family Investment, LLC | 372.7K | 1.10% | — | 372.7K | — | 372.7K | OO | or place of organization | 2022-09-26 | ↗ |
| 13 | Down Trust | — | 0.00% | — | — | — | — | IN | Texas | 2023-10-17 | ↗ |
| 14 | GWG Wind Down Trust | — | 0.00% | — | — | — | — | OO | Texas | 2023-10-17 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | CANTOR FITZGERALD, L. P. | — -19.0K (-100.0%) | — -1.6K (-100.0%) | 0.00% -0.057 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
3
Shares acquired
—
Shares disposed
3.90M
Cash buys
—
Cash sales
3.00
Net activity
-3,900,000
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-09-10 | Langley Trevor | Director | — | I | Class A Common Stock, $0.0001 par value | 0 | 0.00 | — | 1,023,629 | — | ↗ |
| 2024-09-10 | Lagan Seamus | Director | — | I | Class A Common Stock, $0.0001 par value | 0 | 0.00 | — | 1,023,629 | — | ↗ |
| 2024-07-22 | WHITE MARK BRIAN | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 1,300,000 | 0.25 | 325.0K | 0 | — | ↗ |
| 2024-07-22 | WARD MARTIN CHRISTOPHER | Officer / 10% Owner | S-Sale | D | Class A Common Stock | 1,300,000 | 0.25 | 325.0K | 0 | — | ↗ |
| 2024-07-22 | Kr8 ai Inc. | 10% Owner | S-Sale | D | Class A Common Stock | 1,300,000 | 0.25 | 325.0K | 0 | — | ↗ |
| 2024-02-06 | WHITE MARK BRIAN | Director / Officer / 10% Owner | S-Sale | D | Class A Common Stock | 250,000 | 0.42 | 105.0K | 0 | — | ↗ |
| 2024-02-06 | WARD MARTIN CHRISTOPHER | Officer / 10% Owner | S-Sale | D | Class A Common Stock | 250,000 | 0.42 | 105.0K | 0 | — | ↗ |
| 2024-01-19 | WHITE MARK BRIAN | Director / Officer / 10% Owner | A-Award | A | Class A Common Stock | 1,300,000 | 0.00 | — | 1,300,000 | — | ↗ |
| 2024-01-19 | WARD MARTIN CHRISTOPHER | Officer / 10% Owner | A-Award | A | Class A Common Stock | 1,300,000 | 0.00 | — | 1,300,000 | — | ↗ |
| 2024-01-19 | Kr8 ai Inc. | 10% Owner | — | D | Class A Common Stock | 0 | 0.00 | — | 1,300,000 | — | ↗ |
| 2024-01-19 | Christopher Spencer C | 10% Owner | — | I | Class A Common Stock | 0 | 0.00 | — | 1,300,000 | — | ↗ |
| 2023-12-21 | WHITE MARK BRIAN | Director / Officer | G-Gift | D | Class A Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-12-21 | WARD MARTIN CHRISTOPHER | Officer | G-Gift | A | Class A Common Stock | 250,000 | 0.00 | — | 250,000 | — | ↗ |
| 2023-12-14 | WHITE MARK BRIAN | Director / Officer | G-Gift | A | Class A Common Stock | 250,000 | 0.00 | — | 500,000 | — | ↗ |
| 2023-12-14 | WARD MARTIN CHRISTOPHER | Officer | G-Gift | D | Class A Common Stock | 250,000 | 0.00 | — | 0 | — | ↗ |
| 2023-10-03 | WHITE MARK BRIAN | Director / Officer | A-Award | A | Class A Common Stock | 2,500,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2023-10-03 | WARD MARTIN CHRISTOPHER | Officer | A-Award | A | Class A Common Stock | 2,500,000 | 0.00 | — | 2,500,000 | — | ↗ |
| 2023-09-19 | WHITE MARK BRIAN | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-09-19 | WARD MARTIN CHRISTOPHER | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-07-14 | Dowling Vincent J. Jr | 10% Owner | S-Sale | D | Class A Common Stock, par value $0.0001 | 3,000 | 0.16 | 491.10 | 4,647,405 | — | ↗ |
| 2023-06-16 | Dowling Vincent J. Jr | 10% Owner | — | I | Class A Common Stock, par value $0.0001 | 0 | 0.00 | — | 5,756,286 | — | ↗ |
| 2023-05-25 | GWG Holdings, Inc. | 10% Owner | — | D | Class A Common Stock, $0.0001 par value | 0 | 0.00 | — | 4,646,698 | — | ↗ |
| 2023-02-03 | Fay Taylor | Officer | — | D | Stock Option (right to buy) | 2,900 | 6.51 | 18.9K | 0 | — | ↗ |
| 2022-09-16 | Dowling Vincent J. Jr | 10% Owner | — | I | Warrants to purchase Class A Common Stock | 97,333 | 11.50 | 1.12M | 0 | — | ↗ |
| 2022-09-15 | Sabes Jon | Director / Officer / 10% Owner | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-90.2K
Shares Outstanding
29.99M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
| Filing date | Form type | Filing |
|---|---|---|
| 2025-01-06 | DEF 14A | ↗ |
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Celene Laurene Rattray Grant | Chief Financial Officer & Principal Financial and Accounting Officer | — | female |
| Seamus Lagan | Chief Executive Officer & Director | — | male |
| Sylwia Nowak Hauman | Chief Financial Officer & Principal Financial and Accounting Officer | — | female |
ESG Rating
ESG Score History MEDICAL - HEALTHCARE INFORMATION SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for FOXO
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
